DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • Bangladesh
  • /
  • Pharmaceuticals & Biotech
Author Program NEWCreate Narrative
SILCOPHL logo

Silco Pharmaceuticals Limited Stock Price

DSE:SILCOPHL Community·৳1.7b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 2 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

SILCOPHL Share Price Performance

৳16.80
0.70 (4.35%)
​
৳16.80
0.70 (4.35%)
​
Price ৳16.80
Sat, 12 Sep 26
Share Pricen/a

SILCOPHL Community Narratives

There are no narratives available yet.
Create Narrative
There are no community narratives available.

Trending Discussion

No trending discussion available.

Recently Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with slight risk.

4 Risks
0 Rewards
View Full Analysis

Silco Pharmaceuticals Limited Key Details

৳408.7m

Revenue

৳269.4m

Cost of Revenue

৳139.3m

Gross Profit

৳105.1m

Other Expenses

৳34.2m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
0.33
34.09%
8.37%
0%
View Full Analysis

About SILCOPHL

Founded
1995
Employees
313
CEO
Md. Haque Rukan
WebsiteView website
www.silcopharma.com

Silco Pharmaceuticals Limited engages in manufacturing, distribution, and marketing of finished pharmaceutical products in Bangladesh. It offers products in the therapeutic areas of analgesic and antipyretic, anti-platelet, antiasthmatic, antibiotic, antidepressant, antidiabetic, antiemetic, antifungal, antihistamin, antihypertensive and antianginal, antimicrobial, antiprotozoal, antispasmodic, antiulcerant, anxiolytic, calcium and combinations, central muscle relaxants, diuretics, gastroprokinetic, haematinic, vitamins and minerals, laxatives, lipid lowering agents, mycolytic expectorants, and NSAIDs, as well as anti-inflammatory, narcotics, and multi-medicines. The company also exports its medicines to Afghanistan, Bhutan, Myanmar, Ivory Coast, Kenya, Mauritius, Somalia, Tanzania, and Uganda. Silco Pharmaceuticals Limited was incorporated in 1995 and is headquartered in Sylhet, Bangladesh.

Recent SILCOPHL News & Updates

Recent updates

No updates

Silco Pharmaceuticals Limited Competitors

SQURPHARMA logo

Square Pharmaceuticals

Symbol: DSE:SQURPHARMA
Market cap: ৳190.1b
BXPHARMA logo

Beximco Pharmaceuticals

Symbol: DSE:BXPHARMA
Market cap: ৳67.3b
RENATA logo

Renata

Symbol: DSE:RENATA
Market cap: ৳52.6b
BEACONPHAR logo

Beacon Pharmaceuticals

Symbol: DSE:BEACONPHAR
Market cap: ৳23.6b
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide